Aspire Biopharma’s BUZZ BOMB Shows Promising Initial Feedback

Aspire Biopharma Holdings Inc. (NASDAQ:ASBP) is one of the best penny stocks under $1 to buy now. On July 9, Aspire Biopharma Holdings announced positive initial consumer feedback for its new sublingual pre-workout supplement, called BUZZ BOMB.

The product features 50mg of caffeine and provides sustained energy and mental focus to athletes and fitness enthusiasts, using a sublingual nano technology that delivers caffeine rapidly to the bloodstream. This delivery method allows for nearly instant energy.

Aspire Biopharma's BUZZ BOMB Shows Promising Initial Feedback

A line of biopharmaceutical products on a laboratory shelf waiting to be tested.

Aspire began a soft launch of BUZZ BOMB last month and introduced it to strength trainers, consultants, and fitness professionals. The company positions BUZZ BOMB as a science-driven brand focused on optimizing nutrition and performance. Initial production of BUZZ BOMB has already commenced, and the product will be available in 30-unit packs across 4 flavors.

Aspire Biopharma Holdings Inc. (NASDAQ:ASBP) is an early-stage biopharmaceutical company that develops and markets disruptive technology for novel sublingual delivery mechanisms in the US.

While we acknowledge the potential of ASBP to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ASBP and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.